1. Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens

   • Hongdan Gao
   • Zifang Shang
   • Dongli Ma

   Review 21 November 2022 Pages: 881 - 898

2. Clinical and immune response characteristics among vaccinated persons infected with SARS-CoV-2 delta variant: a retrospective study

   • Cunjin Wang
   • Yong Li
   • Ju Gao

   Research Article 21 November 2022 Pages: 899 - 914

3. Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells

   • Shipeng Chen
   • Lian Guan
   • Lin Xu

   Research Article 21 November 2022 Pages: 915 - 930

4. Application of regional citrate anticoagulation in patients at high risk of bleeding during intermittent hemodialysis: a prospective multicenter randomized controlled trial

   • Xiaoyan Tang
   • Dezheng Chen
   • Mingying Mao

   Research Article 21 November 2022 Pages: 931 - 942

5. Combination of Se-methylselenocysteine, D-α-tocopheryl succinate, β-carotene, and l-lysine can prevent cancer metastases using as an adjuvant therapy

   • Yunlong Cheng
   • Shu Lian
   • Lee Jia

   Research Article 21 November 2022 Pages: 943 - 956

6. A method for distinguishing benign and malignant pulmonary nodules based on 3D dual path network aided by K-means clustering analysis

   • Dachuan Gao
   • Xiaodan Ye
   • Shengdong Nie

   Correspondence 21 November 2022 Pages: 957 - 967

7. High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in multiple myeloma

   • Xiaoyan Yue
   • Linlin Huang
   • Jingsong He

   Correspondence 21 November 2022 Pages: 968 - 974